Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles
about
Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemiaDNA sequencing of a cytogenetically normal acute myeloid leukaemia genomeHigh throughput digital quantification of mRNA abundance in primary human acute myeloid leukemia samplesCross-platform analysis of cancer microarray data improves gene expression based classification of phenotypesIn vitro transformation of primary human CD34+ cells by AML fusion oncogenes: early gene expression profiling reveals possible drug target in AMLAML1/ETO proteins control POU4F1/BRN3A expression and function in t(8;21) acute myeloid leukemiaNew data on robustness of gene expression signatures in leukemia: comparison of three distinct total RNA preparation proceduresBioinformatics for medical diagnostics: assessment of microarray data in the context of clinical databases.Gene expression profiles in acute myeloid leukemia with common translocations using SAGE.Proteomic identification of C/EBP-DBD multiprotein complex: JNK1 activates stem cell regulator C/EBPalpha by inhibiting its ubiquitination.Quantitative comparison of microarray experiments with published leukemia related gene expression signatures.Integrative meta-analysis of differential gene expression in acute myeloid leukemiaComprehensive mutational profiling of core binding factor acute myeloid leukemia.Differential Analysis of Genetic, Epigenetic, and Cytogenetic Abnormalities in AMLElevated PIN1 expression by C/EBPalpha-p30 blocks C/EBPalpha-induced granulocytic differentiation through c-Jun in AMLRoutine use of microarray-based gene expression profiling to identify patients with low cytogenetic risk acute myeloid leukemia: accurate results can be obtained even with suboptimal samples.An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemiaAdvances in molecular genetics and treatment of core-binding factor acute myeloid leukemiaArsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype.Origins of chromosome translocations in childhood leukaemia.FHL2 interacts with CALM and is highly expressed in acute erythroid leukemia.Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction.Biology and management of relapsed acute myeloid leukaemia.Molecular genetic analysis of haematological malignancies: I. Acute leukaemias and myeloproliferative disorders.CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900.Systematic analysis of hematopoietic gene expression profiles for prognostic prediction in acute myeloid leukemia.Use of gene expression microarrays for the study of acute leukemia.Gene expression profiling for the diagnosis of acute leukaemia.Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study.Early gene expression of acute myeloid leukemia in response to chemotherapy.A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects.Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profilingAn international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase.Genomic approaches to small molecule discovery.Blood-based transcriptomics: leukemias and beyond.Pharmacogenomics in acute myeloid leukemia.Expression profiling of murine acute promyelocytic leukemia cells reveals multiple model-dependent progression signatures.Genomic characterization of acute leukemias.Prognosis and monitoring of core-binding factor acute myeloid leukemia: current and emerging factors.Human CD34+ cells expressing the inv(16) fusion protein exhibit a myelomonocytic phenotype with greatly enhanced proliferative ability.
P2860
Q21144312-0B7A93FB-5A89-42FA-880B-84B8554DAF83Q24644436-CAE450F8-B100-461E-A110-2FD21A05F2B0Q24652901-86494E68-31AF-48B2-BE71-9E8060651EA7Q24811346-408C3B6E-3FDC-42B6-BA30-1F28AE49F2CAQ28475341-4FB6B464-28C4-4193-87D9-008C7D319EC8Q28751687-67B153F7-D62F-45D4-A710-59AD059B85A1Q31116667-4A5596CA-45B0-4D44-80C8-1AF15125FD38Q33196871-C64BB3F5-CA22-460F-82A7-C029BEEA995BQ33231820-45538BCF-424E-4ABC-A643-C47317B7249AQ33257982-B7B31C05-F64E-4864-B89C-AD12DDBD03A0Q33518038-3E212AC5-0BBA-4DE1-B5CA-D6E95121AC1FQ33538043-97D21DF2-B7E1-427B-86ED-C4F8D25BD589Q33758306-193A99AE-452C-4686-81F1-39157A86D225Q33868160-552DCD97-386D-4C44-AF78-AB005F6E9784Q34072688-3467321B-8132-4091-B341-4ABD39E6036DQ34144877-2B4B607E-F47F-4803-BA34-C2E0157CE021Q34197535-A495EF70-FC60-4A47-A561-99BADC5AA02AQ34598109-6B678DC2-BC9A-42A8-BD9A-2F1350198AD9Q34754867-8692310D-104A-47B8-A0DE-1B0351927FDEQ35210004-67B1BE8E-9868-4F63-B602-4609B2F29F9AQ35668394-131BF11B-5406-46C9-BB63-87F335331211Q35848938-EFB52A1D-F2F2-4BBD-A7EF-5665C7020EFDQ36085026-DFF1E7FF-5E39-4D0D-AB12-174868285B30Q36153422-A5733AD2-7EB2-4EC3-B06A-FD97FA6CFEFFQ36249453-58AB8B35-6870-4AB6-972E-D0284F4769F4Q36310257-22F1A659-562C-4925-BB7A-DD6792B707F5Q36607291-B44C1957-B178-4842-96EA-CE260E7ABA43Q36609901-0C85EA00-E2B8-40BD-A0F5-38B8F0E6EA89Q36678141-A19A3ACA-B643-498B-8EAF-71C6CA84BE0FQ36817144-87150827-502B-4552-9124-7F5FDC6CA3C9Q37041909-00492403-7821-480B-A5CE-DFAA2E0B4065Q37059396-75E8A29A-945E-4D2F-A09F-A573D456636BQ37125395-87DB01CD-17E1-46D6-BDDB-A67257CCF910Q37406963-28C63F52-DF34-4A06-91F0-BE79DB10FC2CQ37451562-1AFEACB1-B31D-4380-8BEA-D7664906F262Q37627876-E5A5ADF8-CE60-42B8-BFC2-A5DACE510227Q37683754-167A81B8-2D76-4303-B59E-C7FFA6F57B3DQ38223490-41D4B4BA-8C60-40A4-A6AE-DDB1D32268B3Q38263126-9C1D73ED-8C70-4862-A3CC-17467159876DQ38288838-91C2BA85-ECA3-4DD5-9BF9-70BBD2266995
P2860
Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Acute myeloid leukemias with r ...... cific gene expression profiles
@ast
Acute myeloid leukemias with r ...... cific gene expression profiles
@en
Acute myeloid leukemias with r ...... cific gene expression profiles
@nl
type
label
Acute myeloid leukemias with r ...... cific gene expression profiles
@ast
Acute myeloid leukemias with r ...... cific gene expression profiles
@en
Acute myeloid leukemias with r ...... cific gene expression profiles
@nl
prefLabel
Acute myeloid leukemias with r ...... cific gene expression profiles
@ast
Acute myeloid leukemias with r ...... cific gene expression profiles
@en
Acute myeloid leukemias with r ...... cific gene expression profiles
@nl
P2093
P2860
P50
P356
P1476
Acute myeloid leukemias with r ...... cific gene expression profiles
@en
P2093
Alexander Kohlmann
Martin Dugas
Susanne Mergenthaler
Wolfgang Hiddemann
Wolfgang Kern
P2860
P304
10008-10013
P356
10.1073/PNAS.142103599
P407
P577
2002-07-08T00:00:00Z